Inovio's Zika vaccine evokes robust response in human study

Dec 21 (Reuters) - Inovio Pharmaceuticals Inc said

its experimental Zika vaccine induced robust immune responses in

an early-stage study in human volunteers who have not been

infected with the virus.

Read more